Angiostatic treatment of neuroblastoma (Q74360584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Angiostatic treatment of neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

E Wassberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Christofferson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

2020-2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

Tumor angiogenesis: therapeutic implications

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Antiangiogenesis as a novel therapeutic concept in pediatric oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

1 reference

7 January 2021

New perspectives in clinical oncology from angiogenesis research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

TNP-470 antiangiogenic therapy for advanced murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Vascular attack as a therapeutic strategy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Successful treatment of infantile hemangiomas with interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900337-7

7 January 2021

10.1016/S0959-8049(97)00337-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9516846%20AND%20SRC:MED&resulttype=core&format=json